Neuroprotective effects of resident microglia following acute brain injury.
Microglia quickly react to various neurodegenerative processes by producing cytokines and eliminating cellular debris via phagocytosis. These events are also associated with an increased proliferation of microglia, which derive from resident progenitors and those present in the bone marrow. However, it is not clear whether the innate immune response by resident or newly differentiated microglia is beneficial or detrimental to the central nervous system. The aim of this study was to determine the impact of an altered immune response following acute excitotoxicity. Sodium nitroprusside (SNP) or kainic acid (KA) was administered in the brain of various groups of mice, and the extent of neurodegeneration, myelin damage, and inflammation was evaluated within a period of 2 weeks. We used synthetic glucocorticoid (GC), myeloid differentiation factor 88 (MyD88)-deficient mice to suppress nuclear factor kappaB (NF-kappaB) signaling and transgenic mice that express the thymidine kinase (TK) protein under the control of the CD11b promoter to determine the role of proliferating and infiltrating microglia in acute models of brain injury. Neurodegeneration was more extensive in GC-treated and MyD88-deficient mice, suggesting that NF-kappaB signaling and microglia activation are potent neuroprotective mechanisms in the presence of SNP. KA was also highly toxic to neurons of the amygdala in MyD88 knockout mice but not in their WT littermates. Although bone marrow-derived cells are clearly attracted to neurodegenerative areas, preventing their infiltration and differentiation did not affect the extent of SNP-related damage. These data indicate that MyD88/NF-kappaB signaling in resident non-proliferating microglia plays a critical role by restricting damage during acute excitotoxicity.
Simard
Alain R
AR
Laboratory of Molecular Endocrinology, CHUL Research Center, Laval University, Québec, Canada G1V 4G2.
Rivest
Serge
S
D000818:Animals; D016026:Bone Marrow Transplantation / Q000379:methods*; D001930:Brain Injuries / Q000139:chemically induced / Q000473:pathology* / Q000503:physiopathology* / Q000517:prevention & control*; D004195:Disease Models, Animal; D005938:Glucocorticoids / Q000008:administration & dosage; D007608:Kainic Acid; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017628:Microglia / Q000502:physiology*; D053594:Myeloid Differentiation Factor 88 / Q000172:deficiency; D016328:NF-kappa B / Q000378:metabolism; D009599:Nitroprusside; D013266:Stilbamidines; D013937:Thymidine Kinase / Q000378:metabolism; D013997:Time Factors
C049774:2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; D005938:Glucocorticoids; C507780:Myd88 protein, mouse; D053594:Myeloid Differentiation Factor 88; D016328:NF-kappa B; D013266:Stilbamidines; D009599:Nitroprusside; D013937:Thymidine Kinase; D007608:Kainic Acid